Intensive care treatment of uncontrolled status epilepticus in children: Systematic literature search of midazolam and anesthetic therapies

Pediatric Critical Care Medicine

Volumn 15, Issue 7, 2014, Pages 632-639

  Wilkes, Ryan ^a   Tasker, Robert C ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Anesthesia; Barbiturates; Midazolam; Refractory status epilepticus; Status epilepticus; Super refractory status epilepticus

Indexed keywords

ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; DIAZEPAM; ISOFLURANE; KETAMINE; LORAZEPAM; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; THIOPENTAL; ANTICONVULSIVE AGENT; INTRAVENOUS ANESTHETIC AGENT;

ANESTHESIA; ARTICLE; CHILD CARE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; DISEASE CONTROL; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; EVIDENCE BASED MEDICINE; HUMAN; INDUCED HYPOTHERMIA; INTENSIVE CARE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CHILD; STATUS EPILEPTICUS;

ANESTHETICS, INTRAVENOUS; ANTICONVULSANTS; BARBITURATES; CHILD; HUMANS; INTENSIVE CARE; MIDAZOLAM; STATUS EPILEPTICUS;

EID: 84926124197     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0000000000000173     Document Type: Article

References (38)

1. Chen JW, Wasterlain CG: Status epilepticus: Pathophysiology and management in adults. Lancet Neurol 2006; 5:246-256
2. Chin RF, Neville BG, Peckham C, et al; NLSTEPSS Collaborative Group: Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: Prospective population-based study. Lancet 2006; 368:222-229
3. Eriksson K, Metsäranta P, Huhtala H., et al: Treatment delay and the risk of prolonged status epilepticus. Neurology 2005; 65:1316-1318
4. Lacroix J, Deal C, Gauthier M., et al: Admissions to a pediatric intensive care unit for status epilepticus: A 10-year experience. Crit Care Med 1994; 22:827-832
5. Chin RF, Verhulst L, Neville B.G., et al: Inappropriate emergency management of status epilepticus in children contributes to need for intensive care. J Neurol Neurosurg Psychiatry 2004; 75:1584-1588
6. Abend NS, Dlugos DJ: Treatment of refractory status epilepticus: Literature review and a proposed protocol. Pediatr Neurol 2008; 38:377-390
7. Bleck TP: Refractory status epilepticus. Curr Opin Crit Care 2005; 11:117-120
8. Lowenstein DH: The management of refractory status epilepticus: An update. Epilepsia 2006; 47(SUPPL. 1):35-40
9. Meierkord H, Boon P, Engelsen B., et al; European Federation of Neurological Societies: EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010; 17:348-355
10. Wilkes R, Tasker RC: Pediatric intensive care treatment of uncontrolled status epilepticus. Crit Care Clin 2013; 29:239-257
11. US Food and Drug Administration: Label approved on 04/14/2008 for DIPRIVAN, NDA no. 019627 Available at: http://www.access-data.fda.gov/drugsatfda-docs/label/2008/019627s046lbl.pdf. Accessed March 26, 2014
12. Rivera R, Segnini M, Baltodano A., et al: Midazolam in the treatment of status epilepticus in children. Crit Care Med 1993; 21:991-994
13. Igartua J, Silver P, Maytal J., et al: Midazolam coma for refractory status epilepticus in children. Crit Care Med 1999; 27:1982-1985
14. Singhi S, Murthy A, Singhi P., et al: Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol 2002; 17:106-110
15. Koul RL, Raj Aithala G, Chacko A, et al: Continuous midazolam infusion as treatment of status epilepticus. Arch Dis Child 1997; 76:445-448
16. Koul R, Chacko A, Javed H., et al: Eight-year study of childhood status epilepticus: Midazolam infusion in management and outcome. J Child Neurol 2002; 17:908-910
17. Brevoord JC, Joosten KF, Arts W.F., et al: Status epilepticus: Clinical analysis of a treatment protocol based on midazolam and phenytoin. J Child Neurol 2005; 20:476-481
18. Ozdemir D, Gulez P, Uran N., et al: Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus. Seizure 2005; 14:129-132
19. Morrison G, Gibbons E, Whitehouse WP: High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med 2006; 32:2070-2076
20. Hayashi K, Osawa M, Aihara M., et al; Research Committee on Clinical Evidence of Medical Treatment for Status Epilepticus in Childhood: Efficacy of intravenous midazolam for status epilepticus in childhood. Pediatr Neurol 2007; 36:366-372
21. Saz EU, Karapinar B, Ozcetin M., et al: Convulsive status epilepticus in children: Etiology, treatment protocol and outcome. Seizure 2011; 20:115-118
22. Kim SJ, Lee DY, Kim JS: Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr Neurol 2001; 25:217-220
23. van Gestel J.P., Blussé van Oud-Alblas HJ, Malingré M, et al: Propofol and thiopental for refractory status epilepticus in children. Neurology 2005; 65:591-592
24. Sakuma H, Awaya Y, Shiomi M., et al: Acute encephalitis with refractory, repetitive partial seizures (AERRPS): A peculiar form of childhood encephalitis. Acta Neurol Scand 2010; 121:251-256
25. Barberio M, Reiter PD, Kaufman J, et al: Continuous infusion pentobarbital for refractory status epilepticus in children. J Child Neurol 2012; 27:721-726
26. Kofke WA, Young RS, Davis P, et al: Isoflurane for refractory status epilepticus: A clinical series. Anesthesiology 1989; 71:653-659
27. Rosati A, L'Erario M, Ilvento L, et al: Efficacy and safety of ketamine in refractory status epilepticus in children. Neurology 2012; 79:2355-2358
28. Guilliams K, Rosen M, Buttram S., et al: Hypothermia for pediatric refractory status epilepticus. Epilepsia 2013; 54:1586-1594
29. Kochanek PM, Carney N, Adelson P.D., et al; American Academy of Pediatrics-Section on Neurological Surgery; American Association of Neurological Surgeons/Congress of Neurological Surgeons; Child Neurology Society; European Society of Pediatric and Neonatal Intensive Care; Neurocritical Care Society; Pediatric Neurocritical Care Research Group; Society of Critical Care Medicine; Paediatric Intensive Care Society UK; Society for Neuroscience in Anesthesiology and Critical Care; World Federation of Pediatric Intensive and Critical Care Societies: Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents-Second edition. Pediatr Crit Care Med 2012; 13(SUPPL. 1):S1-S82
30. Raspall-Chaure M., Chin RF, Neville B.G., et al: Outcome of paediatric convulsive status epilepticus: A systematic review. Lancet Neurol 2006; 5:769-779
31. Tasker RC: Electroencephalographic seizure activity in the comatose critically ill child: Getting closer to knowing what to do. Crit Care Med 2013; 41:362-363
32. Sanchez SM, Carpenter J, Chapman K.E., et al; Pediatric Critical Care EEG Group: Pediatric ICU EEG monitoring: Current resources and practice in the United States and Canada. J Clin Neurophysiol 2013; 30:156-160
33. Kramer U, Chi CS, Lin K.L., et al: Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome: A multicenter study on 77 children. Epilepsia 2011; 52:1956-1965
34. Kramer U, Chi CS, Lin K.L., et al: Febrile infection-related epilepsy syndrome (FIRES): Does duration of anesthesia affect outcome? Epilepsia 2011; 52(SUPPL. 8):28-30
35. Sutter R, Marsch S, Fuhr P., et al: Anesthetic drugs in status epilepticus: Risk or rescue? A 6-year cohort study. Neurology 2014; 82:656-664
36. Fountain NB, Fugate JE: Refractory status epilepticus: What to put down: The anesthetics or the patient? Neurology 2014; 82:650-651
37. Shorvon S, Ferlisi M: The treatment of super-refractory status epilepticus: A critical review of available therapies and a clinical treatment protocol. Brain 2011; 134:2802-2818
38. Shorvon S: Super-refractory status epilepticus: An approach to therapy in this difficult clinical situation. Epilepsia 2011; 52(SUPPL. 8):53-56